{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:35:46Z","timestamp":1773660946616,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:00:00Z","timestamp":1410220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s13277-014-2560-2","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T15:47:23Z","timestamp":1410191243000},"page":"12427-12434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF"],"prefix":"10.1007","volume":"35","author":[{"given":"Li-qiang","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-tao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-chun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-fang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-cong","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,9]]},"reference":[{"key":"2560_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2560_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/jca.7810","volume":"5","author":"CS Marcus","year":"2014","unstructured":"Marcus CS, Maxwell GL, Darcy KM, et al. Current approaches and challenges in managing and monitoring treatment response in ovarian cancer. J Cancer. 2014;5(1):25\u201330.","journal-title":"J Cancer"},{"key":"2560_CR3","first-page":"83","volume":"3","author":"GC Shukla","year":"2011","unstructured":"Shukla GC, Singh J, Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3:83\u201392.","journal-title":"Mol Cell Pharmacol"},{"key":"2560_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-642-31659-3_5","volume":"158","author":"JJ Xi","year":"2013","unstructured":"Xi JJ. MicroRNAs in cancer. Cancer Treat Res. 2013;158:119\u201337.","journal-title":"Cancer Treat Res"},{"key":"2560_CR5","doi-asserted-by":"crossref","first-page":"e69784","DOI":"10.1371\/journal.pone.0069784","volume":"8","author":"X Liang","year":"2013","unstructured":"Liang X, Zeng J, Wang L, Fang M, Wang Q, Zhao M, et al. Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212. PLoS ONE. 2013;8:e69784.","journal-title":"PLoS ONE"},{"key":"2560_CR6","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/jcb.24613","volume":"114","author":"Z Jiping","year":"2013","unstructured":"Jiping Z, Ming F, Lixiang W, Xiuming L, Yuqun S, Han Y, et al. MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2. J Cell Biochem. 2013;114:2666\u201372.","journal-title":"J Cell Biochem"},{"issue":"2","key":"2560_CR7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.gastro.2013.04.004","volume":"145","author":"X Meng","year":"2013","unstructured":"Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y, et al. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Gastroenterology. 2013;145(2):426\u201336.","journal-title":"Gastroenterology"},{"key":"2560_CR8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","volume":"20","author":"R Sankaranarayanan","year":"2006","unstructured":"Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20:207\u201325.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2560_CR9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1091\/mbc.E11-09-0777","volume":"23","author":"Y Li","year":"2012","unstructured":"Li Y, Zhang D, Chen C, et al. MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell. 2012;23:1423\u201334.","journal-title":"Mol Biol Cell"},{"key":"2560_CR10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-9966-33-54","volume":"33","author":"C Ma","year":"2014","unstructured":"Ma C, Nong K, Wu B, et al. miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. J Exp Clin Cancer Res. 2014;33:54.","journal-title":"J Exp Clin Cancer Res"},{"key":"2560_CR11","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1126\/science.1840698","volume":"251","author":"S Higashiyama","year":"1991","unstructured":"Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 1991;251:936\u20139.","journal-title":"Science"},{"key":"2560_CR12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/bbrc.1994.2500","volume":"204","author":"G Raab","year":"1994","unstructured":"Raab G, Higashiyama S, Hetelekidis S, et al. Biosynthesis and processing by phorbol ester of the cells surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem Biophys Res Commun. 1994;204:592\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2560_CR13","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1016\/S0021-9258(18)42682-8","volume":"267","author":"S Higashiyama","year":"1992","unstructured":"Higashiyama S, Lau K, Besner GE, et al. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem. 1992;267:6205\u201312.","journal-title":"J Biol Chem"},{"key":"2560_CR14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.122.4.933","volume":"122","author":"S Higashiyama","year":"1993","unstructured":"Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol. 1993;122:933\u201340.","journal-title":"J Cell Biol"},{"key":"2560_CR15","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1073\/pnas.90.9.3889","volume":"90","author":"M Marikovsky","year":"1993","unstructured":"Marikovsky M, Breuing K, Liu PY, et al. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci U S A. 1993;90:3889\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2560_CR16","doi-asserted-by":"crossref","first-page":"20060","DOI":"10.1016\/S0021-9258(17)32127-0","volume":"269","author":"K Hashimoto","year":"1994","unstructured":"Hashimoto K, Higashiyama S, Asada H, et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem. 1994;269:20060\u20136.","journal-title":"J Biol Chem"},{"key":"2560_CR17","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1073\/pnas.92.14.6547","volume":"92","author":"GE Peoples","year":"1995","unstructured":"Peoples GE, Blotnick S, Takahashi K, et al. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc Natl Acad Sci U S A. 1995;92:6547\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2560_CR18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1083\/jcb.128.5.929","volume":"128","author":"S Higashiyama","year":"1995","unstructured":"Higashiyama S, Iwamoto R, Goishi K, et al. The membrane protein CD9\/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol. 1995;128:929\u201338.","journal-title":"J Cell Biol"},{"key":"2560_CR19","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/j.1460-2075.1994.tb06516.x","volume":"13","author":"R Iwamoto","year":"1994","unstructured":"Iwamoto R, Higashiyama S, Mitamura T, et al. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27\/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 1994;13:2322\u201330.","journal-title":"EMBO J"},{"issue":"3","key":"2560_CR20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbrc.2007.11.015","volume":"365","author":"F Yotsumoto","year":"2008","unstructured":"Yotsumoto F, Yagi H, Suzuki SO, et al. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun. 2008;365(3):555\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"2560_CR21","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1158\/0008-5472.CAN-04-0811","volume":"64","author":"S Miyamoto","year":"2004","unstructured":"Miyamoto S, Hirata M, Yamazaki A, et al. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res. 2004;64:5720\u20137.","journal-title":"Cancer Res"},{"key":"2560_CR22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3892\/or.2011.1616","volume":"27","author":"Y Ohnishi","year":"2012","unstructured":"Ohnishi Y, Inoue H, Furukawa M, et al. Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma. Oncol Rep. 2012;27:954\u20138.","journal-title":"Oncol Rep"},{"key":"2560_CR23","first-page":"1184","volume":"56","author":"DR Haugen","year":"1996","unstructured":"Haugen DR, Akslen LA, Varhaug JE, et al. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. Cancer Res. 1996;56:1184\u20138.","journal-title":"Cancer Res"},{"key":"2560_CR24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<106::AID-IJC17>3.0.CO;2-9","volume":"78","author":"LA Chandler","year":"1998","unstructured":"Chandler LA, Sosnowski BA, McDonald JR, et al. Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein. Int J Cancer. 1998;78:106\u201311.","journal-title":"Int J Cancer"},{"key":"2560_CR25","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3892\/or.2013.2659","volume":"30","author":"I Ota","year":"2013","unstructured":"Ota I, Higashiyama S, Masui T, et al. Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells. Oncol Rep. 2013;30:1593\u2013600.","journal-title":"Oncol Rep"},{"key":"2560_CR26","doi-asserted-by":"crossref","unstructured":"Zhou Z N, Sharma V P, Beaty B T, et al. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene, 2013.","DOI":"10.1038\/onc.2013.363"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2560-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2560-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2560-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T12:15:03Z","timestamp":1650111303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2560-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,9]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2560"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2560-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726701826.793522754","asserted-by":"object"}]},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,9]]}}}